These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24332142)

  • 1. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
    Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
    Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial.
    Kulik A; Desai NR; Shrank WH; Antman EM; Glynn RJ; Levin R; Reisman L; Brennan T; Choudhry NK
    Circulation; 2013 Sep; 128(11 Suppl 1):S219-25. PubMed ID: 24030410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
    J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full coverage for preventive medications after myocardial infarction.
    Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH;
    N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
    Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
    JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of pre- and posthospital medication adherence in myocardial infarction patients.
    Doll JA; Hellkamp AS; Thomas L; Fonarow GC; Peterson E; Wang TY
    Am Heart J; 2019 Feb; 208():74-80. PubMed ID: 30580129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
    Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
    Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
    Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
    BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART).
    Calvin JE; Shanbhag S; Avery E; Kane J; Richardson D; Powell L
    Congest Heart Fail; 2012; 18(2):73-8. PubMed ID: 22432552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
    Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
    Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
    Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.